Home Newsfeeds JP Morgan Maintains Underweight on Kimberly-Clark, Lowers Price Target to $117

JP Morgan Maintains Underweight on Kimberly-Clark, Lowers Price Target to $117

JP Morgan analyst Andrea Teixeira maintains Kimberly-Clark (NYSE:KMB) with a Underweight and lowers the price target from $118 to $117.

byBenzinga Newsdesk

October 13, 2022

1 minute read

JP Morgan analyst Andrea Teixeira maintains Kimberly-Clark (NYSE:KMB) with a Underweight and lowers the price target from $118 to $117.

News

‘Takeover Rumors Swirl Around Internet Giant Akamai’ – Boston Globe

By Benzinga Newsdesk

October 25, 3:40 PM

Takeover rumors swirl around Internet giant Akamai - The Boston Globe Cambridge Internet pioneer Akamai Technologies has been on an acquisition binge over the past year as it tries to expand in cybersecurity. Now the

AKAM

News

‘Coinbase Launches Subscription Service With Focus On European Expansion; Coinbase One Will Launch In 35 Countries, Starting With U.S., UK, Germany And Ireland’ – TechCrunch

By Happy Mohamed

May 18, 11:44 AM

https://techcrunch.com/2023/05/18/coinbase-one-subscription-launch/ Coinbase, the world’s second-largest crypto exchange, is launching its subscription service, Coinbase One, in 35 countries in a bid to

COIN

Global
News

Impressive Chinese Debut Pushes “Oppenheimer” Past $170M In IMAX Global Box Office

By Happy Mohamed

September 5, 8:34 AM

IMAX® Reaps Massive 30% Share of Opening Weekend Box Office in China for Christopher Nolan Masterpiece on Only 721 Screens NEW YORK, Sept. 5, 2023 /PRNewswire/ -- IMAX Corporation

IMAX

FDA
News

AbbVie Announces RINVOQ (Upadacitinib) Receives Sixth U.S. FDA Approval

By Michael Horton

October 21, 5:00 PM

AbbVie (NYSE:ABBV) today announces that the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib 15 mg, once daily), an oral therapy, for the treatment of adults with active

ABBV

JP Morgan Maintains Underweight on Kimberly-Clark, Lowers Price Target to $117

Related Posts

‘Takeover Rumors Swirl Around Internet Giant Akamai’ – Boston Globe

‘Coinbase Launches Subscription Service With Focus On European Expansion; Coinbase One Will Launch In 35 Countries, Starting With U.S., UK, Germany And Ireland’ – TechCrunch

Impressive Chinese Debut Pushes “Oppenheimer” Past $170M In IMAX Global Box Office

AbbVie Announces RINVOQ (Upadacitinib) Receives Sixth U.S. FDA Approval